tiprankstipranks
Advertisement
Advertisement

CMND Stock Latest News

Clearmind Medicine advances CMND-100 to Alcohol Use Disorder patients
The FlyClearmind Medicine advances CMND-100 to Alcohol Use Disorder patients
5d ago
CMND
Psychedelic: Definium’s LSD-based pill meets endpoints in GAD study
PremiumThe Fly
Psychedelic: Definium’s LSD-based pill meets endpoints in GAD study
5d ago
LLY
ATAI
Clearmind Medicine reports MEAI development program permeation study results
PremiumThe Fly
Clearmind Medicine reports MEAI development program permeation study results
10d ago
CMND
Psychedelic: Compass Pathways, GH Research report quarterly earnings
PremiumThe Fly
Psychedelic: Compass Pathways, GH Research report quarterly earnings
15d ago
CMND
CMPS
Clearmind Medicine reports DSMB approves advancing Phase I/II AUD study
PremiumThe Fly
Clearmind Medicine reports DSMB approves advancing Phase I/II AUD study
15d ago
CMND
Psychedelic: Clearmind reports safety findings for CMND-100
PremiumThe FlyPsychedelic: Clearmind reports safety findings for CMND-100
22d ago
CMND
CMPS
Clearmind Medicine announces safety results from Part A of CMND-100 tral
Premium
The Fly
Clearmind Medicine announces safety results from Part A of CMND-100 tral
22d ago
CMND
Clearmind Medicine completes Part A of CMND-100 trial
Premium
The Fly
Clearmind Medicine completes Part A of CMND-100 trial
24d ago
CMND
Psychedelic: PharmAla enters license agreement with Jupiter Neurosciences
PremiumThe Fly
Psychedelic: PharmAla enters license agreement with Jupiter Neurosciences
29d ago
LLY
ATAI
Clearmind files psychedelic patent application with Hong Kong Patent Office
PremiumThe Fly
Clearmind files psychedelic patent application with Hong Kong Patent Office
1M ago
CMND
Clearmind reports positive retention results for intranasal formulation of MEAI
PremiumThe Fly
Clearmind reports positive retention results for intranasal formulation of MEAI
1M ago
CMND
FDA announces availability of final guidance for psychedelic drug research
PremiumThe Fly
FDA announces availability of final guidance for psychedelic drug research
1M ago
ATAI
CMND
Clearmind Medicine submits response to HHS request for information
PremiumThe FlyClearmind Medicine submits response to HHS request for information
1M ago
CMND
Psychedelic: Compass Pathways reports six-month data for psilocybin drug
Premium
The Fly
Psychedelic: Compass Pathways reports six-month data for psilocybin drug
1M ago
ATAI
CMND
Psychedelic: Helus Pharma reports FY26 financial results
Premium
The Fly
Psychedelic: Helus Pharma reports FY26 financial results
2M ago
CMND
CMPS
Psychedelic: Definium soars on study results for LSD-based depression treatment
PremiumThe Fly
Psychedelic: Definium soars on study results for LSD-based depression treatment
2M ago
ATAI
CMND
Clearmind completes treatment for all participants in Part A of CMND-100 trial
PremiumThe Fly
Clearmind completes treatment for all participants in Part A of CMND-100 trial
2M ago
CMND
Psychedelic: Clearmind completes Part A dosing for Phase I/II CMND-100 trial
PremiumThe Fly
Psychedelic: Clearmind completes Part A dosing for Phase I/II CMND-100 trial
2M ago
CMND
JAGX
Clearmind Medicine granted U.S. patent for Binge Behavior Regulators
PremiumThe Fly
Clearmind Medicine granted U.S. patent for Binge Behavior Regulators
2M ago
CMND
Clearmind Medicine completes dosing for four cohorts of CMND-100 trial
PremiumThe FlyClearmind Medicine completes dosing for four cohorts of CMND-100 trial
2M ago
CMND
Psychedelic: Enveric initiates IND-enabling genotoxicity studies of EB-003
Premium
The Fly
Psychedelic: Enveric initiates IND-enabling genotoxicity studies of EB-003
3M ago
CMND
ENVB
Clearmind Medicine files Japanese patent application for 5-Methoxy-2-aminoindan
Premium
The Fly
Clearmind Medicine files Japanese patent application for 5-Methoxy-2-aminoindan
3M ago
CMND

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >